花园生物
(300401)
| 流通市值：78.64亿 | | | 总市值：79.92亿 |
| 流通股本：5.36亿 | | | 总股本：5.45亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 692,107,564.32 | 276,882,853.78 | 1,237,398,520.91 | 935,701,786.71 |
| 营业总成本 | 550,775,328.81 | 226,825,639.48 | 901,092,612.99 | 681,596,217.82 |
| 其他经营收益 | | | | |
| 营业利润 | 149,285,588.49 | 56,783,754.14 | 350,034,452.01 | 264,353,172.41 |
| 利润总额 | 149,386,364.55 | 56,914,692.33 | 352,501,057.1 | 268,828,010.95 |
| 净利润 | 131,920,754.06 | 50,269,797.81 | 304,858,290.96 | 234,054,618.77 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 131,920,754.06 | 50,269,797.81 | 304,858,290.96 | 234,054,618.77 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 2,468,013,020.98 | 2,587,631,851.56 | 2,416,357,393.96 | 2,562,596,035.55 |
| 非流动资产: | | | | |
| 非流动资产合计 | 3,462,626,482.1 | 3,421,471,442.81 | 3,365,432,983.48 | 3,350,727,737.95 |
| 资产总计 | 5,930,639,503.08 | 6,009,103,294.37 | 5,781,790,377.44 | 5,913,323,773.5 |
| 流动负债: | | | | |
| 流动负债合计 | 1,133,547,786.24 | 1,242,488,407.08 | 958,115,543.07 | 1,244,982,981.37 |
| 非流动负债: | | | | |
| 非流动负债合计 | 1,221,548,858.76 | 1,224,718,750.83 | 1,334,588,536.77 | 1,250,059,023.89 |
| 负债合计 | 2,355,096,645 | 2,467,207,157.91 | 2,292,704,079.84 | 2,495,042,005.26 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 3,575,556,247.16 | 3,541,907,814.75 | 3,489,096,425.46 | 3,418,290,345.82 |
| 股东权益合计 | 3,575,542,858.08 | 3,541,896,136.46 | 3,489,086,297.6 | 3,418,281,768.24 |
| 负债和股东权益合计 | 5,930,639,503.08 | 6,009,103,294.37 | 5,781,790,377.44 | 5,913,323,773.5 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 814,712,574.51 | 443,190,633.34 | 1,380,269,533.17 | 1,040,174,221.22 |
| 经营活动现金流出小计 | 619,992,227.62 | 243,572,671.96 | 905,531,279.39 | 694,937,547.6 |
| 经营活动产生的现金流量净额 | 194,720,346.89 | 199,617,961.38 | 474,738,253.78 | 345,236,673.62 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,323,758,205.48 | 572,048,126.03 | 1,500,130,513.19 | 1,188,004,476.88 |
| 投资活动现金流出小计 | 1,168,852,026.69 | 498,211,729.94 | 2,110,288,516.67 | 1,718,612,302.3 |
| 投资活动产生的现金流量净额 | 154,906,178.79 | 73,836,396.09 | -610,158,003.48 | -530,607,825.42 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 529,000,000 | 330,000,000 | 1,245,910,936.95 | 697,100,000 |
| 筹资活动现金流出小计 | 441,969,909.04 | 107,686,978.29 | 1,454,161,992.22 | 560,675,228.55 |
| 筹资活动产生的现金流量净额 | 87,030,090.96 | 222,313,021.71 | -208,251,055.27 | 136,424,771.45 |
| 汇率变动对现金及现金等价物的影响 | -7,830,291.98 | -5,049,399.53 | 532,666.51 | 2,413,364.66 |
| 现金及现金等价物净增加额 | 428,826,324.66 | 490,717,979.65 | -343,138,138.46 | -46,533,015.69 |
| 期末现金及现金等价物余额 | 1,353,149,984.77 | 1,415,041,639.76 | 924,323,660.11 | 1,220,928,782.88 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 428,826,324.66 | - | -343,138,138.46 | - |